Impact of Antiretroviral Therapy on the Risk of Recurrence in HIV-1 Infected Patients with Kaposi Sarcoma: A Multicenter Cohort Experience

Kaposi sarcoma (KS) remains a relevant malignancy in human immunodeficiency virus (HIV)-infected patients with a non-standardized management; despite past suggestions that ritonavir-boosted protease inhibitor (bPI)-based regimens could be preferable, no combination antiretroviral therapy (cART) regi...

Descripción completa

Detalles Bibliográficos
Autores principales: Colafigli, Manuela, Ciccullo, Arturo, Borghetti, Alberto, Fanti, Iuri, Melis, Federico, Modica, Sara, Uccella, Ilaria, Bonadies, Antonio, Ferraresi, Virginia, Anzalone, Enza, Pennica, Alfredo, Migliano, Emilia, Rossetti, Barbara, Madeddu, Giordano, Cauda, Roberto, Cristaudo, Antonio, Di Giambenedetto, Simona, Latini, Alessandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947508/
https://www.ncbi.nlm.nih.gov/pubmed/31771172
http://dx.doi.org/10.3390/jcm8122062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947508/
https://www.ncbi.nlm.nih.gov/pubmed/31771172
http://dx.doi.org/10.3390/jcm8122062

Ejemplares similares